Funded Startups in Switzerland
Disclosed funding in this Switzerland snapshot is led by a sharp outlier: MoonLake Immunotherapeutics raised $200M on 2026-06-23, which dwarfs the next-hig…
Disclosed funding in this Switzerland snapshot is led by a sharp outlier: MoonLake Immunotherapeutics raised $200M on 2026-06-23, which dwarfs the next-highest disclosed round of $152M (Vaderis Therapeutics on 2026-08-11). After that, the largest disclosed cluster is still materially lower, with the next tiers at $70M (SWISSto12, 2026-07-16) and $26M (Zuriq, 2026-07-28), while most other disclosed rounds sit closer to the $1M–$10M band.
The date window runs from 2026-06-10 to 2026-08-13, and the most recent entries concentrate on 2026-08-13 and 2026-08-11 (Aisot Technologies $2M on 2026-08-13; Vaderis Therapeutics $152M on 2026-08-11; Navifare $2M on 2026-08-11). Geography also shows clustering around Zürich versus city-level spread: Zürich appears 16 times (including Aisot Technologies, Zuriq, and Aylight), while Lausanne appears 8 times (including Isospec Analytics and MoleSense), and Rotkreuz appears twice (Navifare on 2026-08-11 and SCAIT on 2026-06-11).
Most recent rounds
50 of 877827 more funded startups
This page shows the 50 most recent rounds (back to Jun 2026). The full 877-company history for this listing opens on a FundedIQ plan.
Unlock all 877 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which disclosed round is the size outlier, and how far ahead is it of the rest?
MoonLake Immunotherapeutics is the standout with $200M on 2026-06-23. The next-highest disclosed round is $152M (Vaderis Therapeutics on 2026-08-11), and the remaining top disclosed amounts step down to $70M (SWISSto12, 2026-07-16) and $26M (Zuriq, 2026-07-28).
Do specific cities concentrate the activity in this country view?
Yes, Zürich is the clear concentration point with 16 listed appearances (e.g., Aisot Technologies $2M on 2026-08-13; Zuriq $26M on 2026-07-28; Aylight $5M on 2026-07-06). Lausanne follows with 8 appearances (Isospec Analytics $490K on 2026-06-23; MoleSense $110K on 2026-06-23), while Rotkreuz appears twice (Navifare $2M on 2026-08-11; SCAIT undisclosed on 2026-06-11).
What does the stage mix suggest across disclosed and undisclosed rounds?
Stage labeling is dominated by Series Unknown (22 of the 50 rows), with Seed (12) and Pre-Seed (10) also prominent, plus fewer later rounds (Series B: 3; Series A: 2; Series C: 1). Undisclosed amounts are present in 11 of 50 rows, so comparisons of “largest” and “smallest” rely only on the 39 disclosed entries.
Are the larger disclosed rounds clustered in time near the top of the list?
They do cluster toward mid-to-late June and mid-July within the shown range (2026-06-10 to 2026-08-13). For example, the top two disclosed rounds are within about six weeks (MoonLake $200M on 2026-06-23; Vaderis $152M on 2026-08-11), and another large disclosed entry appears in that same general window with SWISSto12 at $70M on 2026-07-16.
Which sectors appear most often, and where do the biggest tickets sit?
The most repeated sectors in this list are Artificial Intelligence (AI) (10) and Biotechnology (10), followed by Software (5) and Energy (5). The largest disclosed tickets include Biotechnology’s MoonLake Immunotherapeutics at $200M on 2026-06-23 and Vaderis Therapeutics at $152M on 2026-08-11, indicating outsized funding in biotech alongside high AI/biotech representation overall.
Know who just raised. Then know who to call.
Every newly funded startup with its round, its investors, and its founders — delivered weekly, or searchable back to 2020.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.